FDA Supports Marijuana Clinical Trials

The Food and Drug Administration says it supports clinical trials to determine whether marijuana is safe and effective to treat certain diseases.

In a post on its agency website, the FDA said Friday it has not approved marijuana for general medical use but supports research into the health benefits of the drug.

“Although the FDA has not approved any drug product containing or derived from botanical marijuana, the FDA is aware that there is considerable interest in its use to attempt to treat a number of medical conditions, including, for example, glaucoma, AIDS wasting syndrome, neuropathic pain, cancer, multiple sclerosis, chemotherapy-induced nausea, and certain seizure disorders,” the agency said.

The FDA says it has approved trials for medical marijuana and has been in contact with states where medical marijuana is not legal but state authorities are interested in conducting trials to ensure they do not break federal laws.